Evidence map›Paper›PMID 10934233›Full record

ArticleThe Journal of experimental medicine2000

Activating Ly-49D and inhibitory Ly-49A natural killer cell receptors demonstrate distinct requirements for interaction with H2-D(d).

M C Nakamura, S Hayashi, E C Niemi, J C Ryan, W E Seaman

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

M C NakamuraDepartment of Medicine, University of California, San Francisco, California 94143, USA. marynak@itsa.ucsf.edu
S Hayashi
E C Niemi
J C Ryan
W E Seaman
San Francisco VA Medical Center · US

Funding

XRAY CRYSTALLOGRAPHIC STRUCTURE ANALYSIS: PROTEIN SORTINGP41RR001081 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BABBITT, PATRICIA CLEMENT · 1985 to 2011
$17.6M
LIGANDS FOR NKR P1--A RECEPTOR ON NATURAL KILLER CELLSK11AR001927 · NIAMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI NAKAMURA, MARY C · 1994 to 1998
–
TRANSMEMBRANE SIGNALING BY LY-49R01CA069299 · NCI · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI SEAMAN, WILLIAM E · 1996 to 1999
–
NCI NIH HHS R01 CA69299NCRR NIH HHS P41 RR001081NIAMS NIH HHS K11 AR01927
6 · The paper itself

Abstract

The activating Ly-49D receptor and the inhibitory Ly-49A receptor mediate opposing effects on natural killer (NK) cell cytotoxicity after interaction with the same major histocompatibility complex ligand, H2-D(d). To compare Ly-49D and Ly-49A interactions with H2-D(d), we created mutations in H2-D(d) and examined the functional ability of these mutants to activate lysis through Ly-49D or to inhibit lysis through Ly-49A. Specific single amino acid changes in either the H2-D(d) alpha(1) helix or the alpha(2) helix abrogated Ly-49D-mediated cytotoxicity, but these changes had no significant effect on Ly-49A-dependent inhibition. Each of three alpha(2) domain mutations in the floor of the peptide binding groove reduced functional recognition by either Ly-49D or Ly-49A, but all three were required to fully abrogate inhibition by Ly-49A. Our studies indicate that Ly-49D/H2-D(d) interactions require distinct determinants compared with Ly-49A/H2-D(d) interactions. These differences have important implications for the integration of activating and inhibitory signals in NK cells.

Indexed as

Amino Acid SubstitutionAnimalsAntigens, LyCarrier ProteinsH-2 AntigensHistocompatibility Antigen H-2DKiller Cells, NaturalLectins, C-TypeMembrane GlycoproteinsMembrane ProteinsMiceMutagenesisPeptidesProtein Structure, TertiaryReceptors, ImmunologicReceptors, NK Cell Lectin-LikeAntigens, LyCarrier ProteinsH-2 AntigensHistocompatibility Antigen H-2DLectins, C-TypeMembrane GlycoproteinsMembrane ProteinsPeptidesReceptors, ImmunologicReceptors, NK Cell Lectin-Like

Identifiers

PMID10934233
PMCPMC2193226
OpenAlexW1980344216

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.